| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0096 | 0.9 |